Skip to main content
. 2021 Dec 1;101:103554. doi: 10.1016/j.drugpo.2021.103554

Table 1.

Sample characteristics

Mean (95% CI)
Individuals 324
Gender (%)
Male 59.0 (53.57 to 64.34)
Female 39.8 (34.46 to 45.17)
Other 1.2 (0.03 to 2.44)
Age (%)
20-50 years 49.7 (44.22 to 55.16)
51-56 years 24.4 (19.68 to 29.08)
57-72 years 25.9 (21.13 to 30.72)
Race (%)
NH white 21.3 (16.81 to 25.78)
NH Black 34.6 (29.36 to 39.77)
Hisp/Lat. 38.6 (33.25 to 43.91)
Other 4.6 (2.33 to 6.93)
Missing 0.9 (-0.12 to 1.97)
Education (%)
Less than high school 23.1 (18.53 to 27.77)
High school degree or GED 40.4 (35.06 to 45.80)
Some college/associate's 31.2 (26.10 to 36.24)
College degree 5.2 (2.81 to 7.69)
Employed (%) 25.2 (20.39 to 29.92)
Borough (%)
Manhattan 31.5 (26.40 to 36.57)
Staten Island 2.2 (0.57 to 3.75)
Brooklyn 18.8 (14.55 to 23.11)
Bronx 34.9 (29.66 to 40.09)
Queens 12.7 (9.02 to 16.29)
Married or living as married (%) 23.8 (19.11 to 28.42)
Currently living alone (%) 25.9 (21.13 to 30.72)
Currently homeless (%) 32.8 (27.02 to 38.60)
OUD Severity (%)
Mild 5.6 (3.05 to 8.06)
Moderate 10.5 (7.14 to 13.85)
Severe 84.0 (79.93 to 87.97)
Any heroin injection (%) 37.3 (31.88 to 42.64)
In treatment at study entry (%)a 63.1 (57.45 to 68.79)
Opioid use events protected by naloxone & witness, December 2019-February 2020 (%)b 36.8 (32.93 to 40.72)

Notes: Unless otherwise indicated, estimates refer to each individual's first month participating during the analytic period of interest, April 2020-March 2021.

a

Participants were recruited to and initiated the study between April 2019 and March 2020.

b

For comparison to pre-pandemic levels. N=276 members of the sample cohort participated in at least one survey between 12/2019 and 2/2020.